Neurocrine Biosciences Announces CEO Succession Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 142.44 +1.19 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $141.25 | 52 Week High | $58.46 | |||
| Open | $141.33 | 52 Week Low | $31.25 | |||
| Day High | $143.55 | P/E | N/A | |||
| Day Low | $140.02 | EPS | $-0.69 | |||
| Volume | 1,019,551 | |||||
